Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
385,837,333
-
Total 13F shares
-
14,070,367
-
Share change
-
+281,268
-
Total reported value
-
$256,965,851
-
Put/Call ratio
-
128%
-
Price per share
-
$18.27
-
Number of holders
-
93
-
Value change
-
+$1,941,076
-
Number of buys
-
50
-
Number of sells
-
41
Institutional Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q3 2014
As of 30 Sep 2014,
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,070,367 shares.
The largest 10 holders included
HEARTLAND ADVISORS INC, CARDINAL CAPITAL MANAGEMENT LLC /CT, ACK Asset Management LLC, Lyon Street Capital, LLC, WHITEBOX ADVISORS LLC, THOMSON HORSTMANN & BRYANT INC, Park West Asset Management LLC, BLAIR WILLIAM & CO/IL, CHARTWELL INVESTMENT PARTNERS, INC., and Cortina Asset Management, LLC.
This page lists
93
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.